does semaglutide cause bone loss Study: Weight Drugs Like Ozempic Could Trigger Loss Ozempic Bone Loss Risk: What

The active ingredient, semaglutide, is FDA-approved in branded products (Wegovy, Ozempic), but a compounded preparation is not itself an FDA-approved drug

A recent study investigated the effects of GLP-1R agonists in a multi-hit mouse model in which the combination of a high-fat diet and angiotensin II-induced a cardiometabolic HFpEF phenotype that resembles the human HFpEF phenotype to a large extent characterized by obesity, impaired glucose handling, and metabolic dysregulation accompanied by inflammation

No research supports intermittent dosing protocols

Switching becomes an option if plateau continues despite optimization

Dietary Modulation of Cell Signaling Pathways